Fingerprint
Dive into the research topics of 'Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically